A Study of PHST001 in Advanced Solid Tumors
Conditions
Advanced Solid Tumors · Ovarian Cancer · Endometrial Cancer · Cholangiocarcinoma · CNS Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Precision NextGen Oncology & Research Center, Beverly Hills, California, United States
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States
Stanford University School of Medicine, Palo Alto, California, United States
Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One, Denver, Colorado, United States
Yale Cancer Center, New Haven, Connecticut, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
START Center for Cancer Research - Midwest, Grand Rapids, Michigan, United States
START Center for Cancer Research - Long Island New York, Lake Success, New York, United States
Mount Sinai, New York, New York, United States
Duke Cancer Institute, Durham, North Carolina, United States
Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville, Tennessee, United States
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
START Center for Cancer Research - Texas, Fort Worth, Texas, United States
MD Anderson Cancer Center, Houston, Texas, United States
NEXT Oncology - Dallas, Irving, Texas, United States
South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, United States
University of Texas (UT) Health, San Antonio, Texas, United States
NEXT Oncology - Virginia, Fairfax, Virginia, United States